"The UMC Cancer Center in Lubbock, Texas is a nationally recognized leader in the fight against cancer. Our multi-disciplinary approach combines the expertise of Texas Tech Physicians with UMC's compassionate care and technological advancements. Comprehensive cancer treatment and care is available in one facility, close to home. The CC provides patients with a wide-range of treatment options, as well as support services such as acupuncture, counseling, nutritional support and more! Above all, we want to give our patients a voice. What sets us apart from other cancer centers is that we truly take the time to listen to our patients and respond with compassion. In doing so, we empower you in your care."

During the past decade, UMC Cancer Center / UMC Health System conducted 37 clinical trials. In the 10-year time frame, 37 clinical trials started and 21 clinical trials were completed, i.e. on average, 56.8% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 15 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "UMC Cancer Center / UMC Health System" #1 sponsor was "Children's Oncology Group" with 23 trials, followed by "National Cancer Institute (NCI)" with 20 trials sponsored, "SWOG Cancer Research Network" with 17 trials sponsored, "Alliance for Clinical Trials in Oncology" with 6 trials sponsored and "Bristol-Myers Squibb" with 6 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "UMC Cancer Center / UMC Health System" #1 collaborator was "National Cancer Institute (NCI)" with 52 trials as a collaborator, "Canadian Cancer Trials Group" with 3 trials as a collaborator, "Cancer and Leukemia Group B" with 3 trials as a collaborator, "Children's Oncology Group" with 2 trials as a collaborator and "NCIC Clinical Trials Group" with 2 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 27 trials.

According to Clinical.Site data, the most researched conditions in "UMC Cancer Center / UMC Health System" are "B Acute Lymphoblastic Leukemia" (5 trials), "Breast Cancer" (5 trials), "Recurrent Neuroblastoma" (5 trials), "Refractory Neuroblastoma" (5 trials) and "Refractory Non-Hodgkin Lymphoma" (5 trials). Many other conditions were trialed in "UMC Cancer Center / UMC Health System" in a lesser frequency.

Most popular intervention types in "UMC Cancer Center / UMC Health System" are "Drug" (70 trials), "Other" (37 trials), "Procedure" (28 trials), "Biological" (24 trials) and "Radiation" (23 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (22 trials), "Cyclophosphamide" (20 trials), "Vincristine Sulfate" (19 trials), "Questionnaire Administration" (15 trials) and "Doxorubicin Hydrochloride" (13 trials). Other intervention names were less common.

The vast majority of trials in "UMC Cancer Center / UMC Health System" are 68 trials for "All" genders, 8 trials for "Female" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "UMC Cancer Center / UMC Health System". undefined are not yet recruiting, 26 are recruiting, 28 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in UMC Cancer Center / UMC Health System, 1 suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in UMC Cancer Center / UMC Health System, 2 "Phase 1" clinical trials were conducted, 26 "Phase 2" clinical trials and 48 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".